942308-06-7 Usage
General Description
3-(Methoxymethyl)azetidine hydrochloride is a chemical compound with the formula C5H10NO2Cl. It is an organic compound that has a cyclic structure containing a four-membered ring with a nitrogen and oxygen atom. The hydrochloride salt form of 3-(Methoxymethyl)azetidine is typically used as a reagent in organic synthesis. It can be used in the preparation of various pharmaceutical compounds and as a building block in chemical synthesis. The compound has potential applications in medicinal chemistry and drug development due to its unique structure and reactivity. However, it is important to handle it with caution and in accordance with proper safety protocols due to its potential hazards and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 942308-06-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,2,3,0 and 8 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 942308-06:
(8*9)+(7*4)+(6*2)+(5*3)+(4*0)+(3*8)+(2*0)+(1*6)=157
157 % 10 = 7
So 942308-06-7 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO.ClH/c1-7-4-5-2-6-3-5;/h5-6H,2-4H2,1H3;1H
942308-06-7Relevant articles and documents
VLA-4 INHIBITORY DRUG
-
Page/Page column 90, (2008/12/08)
There is provided a VLA-4 inhibitory drug having good oral absorbability and exhibiting sufficient anti-inflammatory effects when administered orally. A compound represented by the following formula (I): wherein R1 represents a hydrogen atom or a C1-8 alkyl group; R2 represents a hydrogen atom, a halogen atom, a C1-8 alkoxy group, orabenzyloxygroupwhichmaybe substituted; Q represents a monocyclic or bicyclic nitrogen-containing heterocyclic group which may be substituted, and has a nitrogen atom as the bonding site; Y represents an oxygen atom or CH2; W represents a bicyclic aromatic hydrocarbon ring group which may be substituted, or a bicyclic aromatic heterocyclic group whichmaybe substituted; R3a, R3b and R3c each independently represent a hydrogen atom, a halogen atom, a C1-8 alkoxy group or a C1-8 alkyl group; and A1 represents a nitrogen atom or C-R3d (wherein R3d represents a hydrogen atom, a halogen atom, a C1-8 alkoxy group or a C1-8 alkyl group), or a salt thereof, or a VLA-4 inhibitory drug comprising the compound or the salt as an active ingredient.
